99 related articles for article (PubMed ID: 7198476)
1. [Pharmacokinetics of clonidine and chlorthalidone following subacute administration of a fixed combination compared with a sustained release formulation of clonidine alone (author's transl)].
Arndts D; Doevendans J; Arendt G; Rippen G
Arzneimittelforschung; 1981; 31(11):1954-7. PubMed ID: 7198476
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of low clonidine doses in galenic sustained-release preparations. Study with Combipresan 75 perlongettes].
Bibracher C; Podzich M
MMW Munch Med Wochenschr; 1982 May; 124(18):457-8. PubMed ID: 6808370
[No Abstract] [Full Text] [Related]
3. [Therapy of arterial hypertension with a delayed-action clonidine and chlorthalidone combination].
Scali G; Del Vita M; Bompani R
Clin Ter; 1985 Apr; 113(2):111-6. PubMed ID: 4017490
[No Abstract] [Full Text] [Related]
4. Pharmacokinetics of oral sustained release clonidine in humans.
MacGregor TR; Relihan GL; Keirns JJ
Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
[TBL] [Abstract][Full Text] [Related]
5. [Antihypertensive effect of clonidine alone and in combination with chlorthalidone].
Perrotta P
Clin Ter; 1974 Jun; 69(5):465-77. PubMed ID: 4603342
[No Abstract] [Full Text] [Related]
6. [Clinical effects of a clonidine-chlorthalidone combination in the treatment of arterial hypertension].
Antonello A; Campanini M; Glorioso S; Borsatti A; Todesco S
Minerva Med; 1976 Jul; 67(35):2273-81. PubMed ID: 951049
[TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive effects of clonidine and of the clonidine-chlorthalidone combination].
D'Amelio G; Dalla Volta S; De Longhi B; Razzolini R
Minerva Med; 1974 May; 65(41):2342-9. PubMed ID: 4602117
[No Abstract] [Full Text] [Related]
8. A pharmacokinetic and pharmacodynamic assessment of a combined slow-release metoprolol-chlorthalidone preparation.
Kendall MJ; Lambert L; Quarterman CP; John VA
J Clin Hosp Pharm; 1981 Dec; 6(4):259-65. PubMed ID: 7338557
[TBL] [Abstract][Full Text] [Related]
9. [Comparative evaluation of the extended hypotensive effect of slow-released clonidine administered alone or in association with a diuretic].
Bellini G; Battilana G; Rigoni A; Puppis E; Cosenzi A; Carretta R; Fabris B; Tonutti L
Clin Ter; 1983 May; 105(4):295-305. PubMed ID: 6872472
[No Abstract] [Full Text] [Related]
10. Clonidine and chlorthalidone (combipres) in hypertension.
Mroczek WJ; Lee WR; Davidov ME; Finnerty FA
Curr Ther Res Clin Exp; 1975 Jan; 17(1):47-53. PubMed ID: 806428
[No Abstract] [Full Text] [Related]
11. [Clinical trials with clonidine-chlorthalidone, a combined preparation in the treatment of hypertensive diseases].
Dejaco RM; Hartl O
Wien Med Wochenschr; 1973 Feb; 123(7):96-9. PubMed ID: 4631628
[No Abstract] [Full Text] [Related]
12. Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.
Godbillon J; Gerardin A; John VA; Theobald W
Eur J Clin Pharmacol; 1983; 24(5):655-60. PubMed ID: 6873146
[TBL] [Abstract][Full Text] [Related]
13. One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.
Masoni A; Tomasi AM; Pirani R; Lazzaretto R; Ambroso G
G Ital Cardiol; 1981; 11(12):2105-9. PubMed ID: 7346306
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
[TBL] [Abstract][Full Text] [Related]
15. Suprofen sustained release kinetics in healthy male volunteers. 2nd communication: a multiple dose steady-state kinetics of suprofen sustained release tablets during 6 days in healthy male volunteers.
Michos N; Zulliger HW; Möller T; Klein G
Arzneimittelforschung; 1986 Jun; 36(6):949-54. PubMed ID: 3741529
[TBL] [Abstract][Full Text] [Related]
16. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
18. A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Toso M; Valori C; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):249-55. PubMed ID: 7309298
[TBL] [Abstract][Full Text] [Related]
19. [Echocardiographic changes in hypertensive patients treated with a fixed combination of metoprolol and chlorthalidone].
Vincenzi M; De Dominicis E; Lazzaretto R; Mattiello M; Onza I
Minerva Cardioangiol; 1986 Oct; 34(10):625-31. PubMed ID: 3808330
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics and electrocardiographic effects of a new controlled-release form of flecainide acetate: comparison with the standard form and influence of the CYP2D6 polymorphism.
Tennezé L; Tarral E; Ducloux N; Funck-Brentano C
Clin Pharmacol Ther; 2002 Aug; 72(2):112-22. PubMed ID: 12189358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
